Literature DB >> 10204647

Neonatal tetanus: a continuing challenge in the southeast of Turkey: risk factors, clinical features and prognostic factors.

F Gürkan1, M Boşnak, B Dikici, V Boşnak, M A Taş, K Haspolat, I H Kara, I Ozkan.   

Abstract

Neonatal tetanus (NT) still causes significant mortality in developing countries, although in 1989 WHO adopted the goal of eliminating the disease by 1995-2000. To characterize the regional characteristics, clinical charts of 55 neonates (42 males and 13 females) admitted to the Pediatric Infectious Diseases Ward of Dicle University Hospital, Diyarbakir, Turkey with the diagnosis of NT from 1991 to 1997 were reviewed. Mean age at admittance was 8.9+/-4.3 days with a range of 3-25 days. Mean period for the appearance of first symptoms was 5.8 days ranging between 1 and 21 days. Mean birth weight of the patients was 3369+/-560g. All patients were from rural areas and were delivered at home by untrained traditional birth attendants with no prior antenatal healthcare services. Razor blade (55%), scissors (27%), and knife (18%) were the instruments used to cut the cord in non-hygienic conditions. No mothers had prior vaccination with tetanus toxoid during their pregnancy. Spasticity (76%), lack of sucking (71%), trismus (60%), fever (49%), omphalitis (44%), irritability (24%), risus sardonicus (22%), and opithotonus (15%) were the most common presenting signs and symptoms. Age at admission < 7.5 days and symptoms of onset <4.9 days, risus sardonicus and opisthotonus were associated with fatal outcome. All patients were treated with human tetanus immunglobulin or equine tetanus antitoxin where available, antibiotic therapy by penicillin G (100.000 U/kg/day) and intravenous high dose diazepam (40 mg/kg/day). Overall mortality rate was 40% (22 cases), without any equipment for mechanical ventilation. Health education of mothers and birth attendants, promotion of hospital delivery and prenatal tetanus immunization of all pregnant women particularly in rural areas are recommended, if NT is to be prevented.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10204647     DOI: 10.1023/a:1007500109522

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  16 in total

1.  Protective effects of topical antimicrobials against neonatal tetanus.

Authors:  J Bennett; J Macia; H Traverso; S Banoagha; C Malooly; J Boring
Journal:  Int J Epidemiol       Date:  1997-08       Impact factor: 7.196

2.  Infant mortality among various nationalities in the middle part of Guizhou, China.

Authors:  W Huang; H Yu; F Wang; G Li
Journal:  Soc Sci Med       Date:  1997-10       Impact factor: 4.634

3.  Neonatal tetanus: incidence and improved outcome with diazepam.

Authors:  H O Okuonghae; A I Airede
Journal:  Dev Med Child Neurol       Date:  1992-05       Impact factor: 5.449

4.  Neonatal tetanus in the United States: a sentinel event in the foreign-born.

Authors:  A S Craig; G W Reed; R T Mohon; M L Quick; O W Swarner; W L Moore; W Schaffner
Journal:  Pediatr Infect Dis J       Date:  1997-10       Impact factor: 2.129

5.  Neonatal tetanus mortality in Veracruz, Mexico, 1989.

Authors:  V M Cárdenas Ayala; R M Núñez Urquiza; D R Brogan; J M Ibarra Rosales; N Gatica Valdés; T E Smith; S Galván Arriaga; M E Flores Collins; A Escobar Mesa
Journal:  Bull Pan Am Health Organ       Date:  1995-06

6.  Factors affecting prognosis of neonatal tetanus.

Authors:  N Gürses; M Aydin
Journal:  Scand J Infect Dis       Date:  1993

7.  Prenatal tetanus immunization and other practices associated with neonatal tetanus.

Authors:  J C Baltazar; J N Sarol
Journal:  Southeast Asian J Trop Med Public Health       Date:  1994-03       Impact factor: 0.267

8.  Factors associated with neonatal tetanus mortality in northern Nigeria.

Authors:  C O Eregie; G Ofovwe
Journal:  East Afr Med J       Date:  1995-08

9.  A review of 43 cases of tetanus neonatorum.

Authors:  I Yalçin; N Güler; R Kebudi; U Oneş; N Salman
Journal:  Turk J Pediatr       Date:  1992 Jul-Sep       Impact factor: 0.552

10.  The evaluation of late sequelae of tetanus infection.

Authors:  S Tutuncuoglu; E Demir; F Koprubasi; D Selcuki
Journal:  Indian J Pediatr       Date:  1994 May-Jun       Impact factor: 1.967

View more
  4 in total

1.  Topical applications of chlorhexidine to the umbilical cord for prevention of omphalitis and neonatal mortality in southern Nepal: a community-based, cluster-randomised trial.

Authors:  Luke C Mullany; Gary L Darmstadt; Subarna K Khatry; Joanne Katz; Steven C LeClerq; Shardaram Shrestha; Ramesh Adhikari; James M Tielsch
Journal:  Lancet       Date:  2006-03-18       Impact factor: 79.321

2.  Tetanus immunization in pregnant women. Serum levels of antitetanus antibodies at time of delivery.

Authors:  I Maral; M Cirak; F N Aksakal; Z Baykan; F Kayikcioglu; M A Bumin
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

3.  Neonatal tetanus in Turkey; what has changed in the last decade?

Authors:  Bunyamin Dikici; Hakan Uzun; Ebru Yilmaz-Keskin; Taskin Tas; Ali Gunes; Halil Kocamaz; Capan Konca; Mehmet A Tas
Journal:  BMC Infect Dis       Date:  2008-08-19       Impact factor: 3.090

4.  Predictors of Mortality in Neonates and Infants Hospitalized With Sepsis or Serious Infections in Developing Countries: A Systematic Review.

Authors:  Li Danny Liang; Naima Kotadia; Lacey English; Niranjan Kissoon; J Mark Ansermino; Jerome Kabakyenga; Pascal M Lavoie; Matthew O Wiens
Journal:  Front Pediatr       Date:  2018-10-04       Impact factor: 3.418

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.